Schedule 13G ownership disclosure

Assembly Biosciences Inc

Common Stock, par value $0.001 · CUSIP: 045396207

Event date: 2025-08-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Commodore Capital LP

    Shares: 1,615,981.00 · Class: 9.9%

  • Commodore Capital Master LP

    Shares: 1,615,981.00 · Class: 9.9%

  • Robert Egen Atkinson

    Shares: 1,615,981.00 · Class: 9.9%

  • Michael Kramarz

    Shares: 1,615,981.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001831942-25-000017
Form type
SCHEDULE 13G
Filer
ASSEMBLY BIOSCIENCES, INC.
CIK
CIK 1426800
Filed
Aug 15, 2025
Reporting period
Aug 08, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub